
Wu Capital
Description
Wu Capital is a prominent venture capital and private equity firm based in Beijing, China, with a strategic focus on high-growth sectors within the Chinese market. The firm primarily targets investments in healthcare, consumer goods, high-tech (including TMT), and education, aligning with the evolving economic landscape and domestic consumption trends in China. Founded by Wu Yue, the firm has established itself as a significant player in the Chinese investment ecosystem, deploying capital across various stages of company development.
The firm's investment philosophy emphasizes long-term value creation and partnership with portfolio companies. Wu Capital manages multiple funds, including both RMB-denominated and USD-denominated vehicles, allowing for flexibility in its investment approach and catering to diverse investor bases. The firm's assets under management (AUM) are substantial, reportedly exceeding 10 billion RMB, which translates to approximately 1.4 billion USD, underscoring its capacity to make significant capital commitments. They engage in a multi-stage investment strategy, participating in rounds from early-stage ventures to more mature growth-stage and pre-IPO companies.
Wu Capital typically provides substantial financial backing to its portfolio companies. While specific first check sizes can vary depending on the stage and sector, the firm is known to make investments ranging from tens of millions to hundreds of millions of RMB. This translates to a typical first check size that can range from approximately 2.5 million USD for earlier-stage opportunities to upwards of 25 million USD for more mature, growth-oriented companies. Their strategic involvement often extends beyond capital, offering operational support and industry expertise to help accelerate the growth and market penetration of their investments.
Investor Profile
Wu Capital has backed more than 22 startups, with 1 new investments in the last 12 months alone. The firm has led 5 rounds, about 23% of its total and boasts 8 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series C, Series A rounds (top funding stages).
- Majority of deals are located in China, United States, Singapore.
- Strong thematic focus on Health Care, Biotechnology, Apps.
- Typical check size: $2.5M – $25M.
Stage Focus
- Series B (32%)
- Series C (27%)
- Series A (27%)
- Post Ipo Equity (5%)
- Series E (5%)
- Series D (5%)
Country Focus
- China (55%)
- United States (41%)
- Singapore (5%)
Industry Focus
- Health Care
- Biotechnology
- Apps
- Artificial Intelligence (Ai)
- Mobile
- Pharmaceutical
- Internet
- Health Diagnostics
- Enterprise
- Mobile Apps
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.